Toggle navigation
Toggle navigation
About Inflarx
Management
Board
Company History
Vision
R&D
About Complement
About C5A
Technology
Pipeline
Clinical Development
Investors
Press Releases
Events & Presentations
SEC and Financial Reports
Share Information
Analyst Coverage
Corporate Governance
Publications & Posters
Annual/Extraordinary General Meetings
Subscribe to our Newsletter
Career
Open Positions
Executive Assistant (m/w) für den CEO
Senior Clinical Trial Manager (m/f)
Global Supply Manager (m/f)
Medical Expert (m/f)
04-2011: InflaRx initiates clinical Phase I study
Home
Investors
Press Releases
InflaRx initiates clinical Phase I study
InflaRx initiates Clinical Phase I Study
InflaRx initiates the clinical phase I trial of its lead drug antibody IFX-1.
